JP2018136179A - Measurement reagent with absorbed protein - Google Patents
Measurement reagent with absorbed protein Download PDFInfo
- Publication number
- JP2018136179A JP2018136179A JP2017030005A JP2017030005A JP2018136179A JP 2018136179 A JP2018136179 A JP 2018136179A JP 2017030005 A JP2017030005 A JP 2017030005A JP 2017030005 A JP2017030005 A JP 2017030005A JP 2018136179 A JP2018136179 A JP 2018136179A
- Authority
- JP
- Japan
- Prior art keywords
- measurement
- reaction
- molecular weight
- insoluble carrier
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
本発明はヘテロジニアスアッセイ法(不均一性測定法)に適し、標識体の担体への非特異吸着量を低減し、低濃度測定における偽高値の発生を回避した測定試薬に関するものである。 The present invention relates to a measurement reagent that is suitable for heterogeneous assay (heterogeneity measurement method), reduces the amount of nonspecific adsorption of a labeled body to a carrier, and avoids the generation of false high values in low concentration measurement.
免疫学的測定法には生体試料中の測定対象物を高感度に測定する方法の一つとして、抗体、抗原等の測定対象物に特異的に結合する物質を担持した不溶性担体を用いるヘテロジニアスアッセイ法が知られている。この方法はB/F分離(担体に結合した標識体と未結合の標識体の分離)を必要とし、免疫反応が終了した担体を洗浄液にて洗浄し、担体上の免疫複合体に含まれる標識体の標識物から生じるシグナルに基づいて測定対象物を定量する。標識体が担体に非特異吸着すると測定対象物を高感度に測定できないため、通常は、測定対象物に特異的に結合する物質を担体に担持したのち、免疫反応に関与しないタンパク質で担体表面の非特異吸着部位を被覆(以下、この操作をブロッキングと表記することもある)する方法がとられている。 As an immunoassay method, a heterogeneous method using an insoluble carrier carrying a substance that specifically binds to an analyte such as an antibody or an antigen is one of the methods for measuring an analyte in a biological sample with high sensitivity. Assay methods are known. This method requires B / F separation (separation of the label bound to the carrier and the unbound label), the carrier after the immune reaction is washed with a washing solution, and the label contained in the immune complex on the carrier The measurement object is quantified based on the signal generated from the body label. Since the measurement target cannot be measured with high sensitivity if the label is non-specifically adsorbed on the carrier, usually a substance that specifically binds to the target is supported on the carrier, and then the protein on the surface of the carrier is not affected by the immune reaction. A method of coating a non-specific adsorption site (hereinafter, this operation is sometimes referred to as blocking) is employed.
特許文献1は、加熱変性して高分子量化(分子量による分画は行っていない)したウシ血清アルブミン(以下、BSAと表記することもある)を用いて免疫学的凝集反応用担体粒子(平均粒径300nm)をブロッキングする方法により、非加熱変性(大部分が単量体)のBSAで担持する従来法に比べて担体の被覆率が向上し、担体粒子間の非特異凝集反応が抑制される方法を開示している。
しかしながら、測定の高感度化を必要とするヘテロジニアスアッセイ法の場合は、前記標識体の担体への僅かな非特異吸着が測定性能を左右することが多く、特許文献1のブロッキング法を用いても標識体の担体への非特異吸着反応は完全には抑制できないため、低濃度検体の測定値が突発的に偽高値化する(陰性検体が陽性であると誤判定される危険性がある)という致命的な問題が解消されず、非特異吸着反応の抑制という点では不十分であった。
However, in the case of a heterogeneous assay method that requires high sensitivity of measurement, the slight non-specific adsorption of the label to the carrier often affects the measurement performance, and the blocking method of
ヘテロジニアスアッセイ法に適し、標識体の担体への非特異吸着量を低減して低濃度測定における偽高値の発生を回避した、再現性の良好な測定試薬を提供する。 Provided is a highly reproducible measurement reagent that is suitable for heterogeneous assay methods, reduces the amount of non-specific adsorption of the labeled substance to the carrier, and avoids the occurrence of false high values in low concentration measurement.
本発明者らは鋭意検討を行った結果、担体のブロッキングに用いるウシ血清アルブミンを変性させて会合成分を得る際、会合しないで存在する成分(単量体を含む)や会合度の低い成分を除去した最適な分子量画分を用いることにより、へテロジニアスアッセイの低濃度測定における再現性が向上し、特に低濃度域の測定値が突発的に偽高値化するという測定試薬にとって致命的な問題が回避できることを見出し、本発明を完成するに至った。 As a result of intensive studies, the present inventors have determined that when bovine serum albumin used for carrier blocking is denatured to obtain an association component, components that are present without being associated (including monomers) and components that have a low degree of association are obtained. By using the optimal molecular weight fraction that has been removed, the reproducibility of low-level measurements in heterogeneous assays has been improved. Especially, it is a fatal problem for measurement reagents in which the measurement values in the low-concentration range suddenly become falsely high. Has been found to be able to be avoided, and the present invention has been completed.
前記課題を解決し、目的を達成するためになされた本発明は、以下の発明を包含する:
すなわち本発明の第一の態様は、
測定対象物を特異的反応により捕捉する一以上の反応特異的成分と、ウシ血清アルブミンの会合成分(分子量範囲300,000〜1,000,000に入る分子量画分)を担持した不溶性担体である。
The present invention made to solve the above-mentioned problems and achieve the object includes the following inventions:
That is, the first aspect of the present invention is:
It is an insoluble carrier carrying one or more reaction-specific components for capturing a measurement object by a specific reaction and an association component of bovine serum albumin (molecular weight fraction falling in the molecular weight range of 300,000 to 1,000,000). .
次に、本発明の第二の態様は、
上述した不溶性担体を希釈液で懸濁した懸濁液である測定試薬及び前記懸濁液を凍結乾燥した測定試薬である。
Next, the second aspect of the present invention is as follows.
A measurement reagent which is a suspension in which the above-described insoluble carrier is suspended in a diluent, and a measurement reagent obtained by lyophilizing the suspension.
次に、本発明の第三の態様は、
上述した測定試薬に試料を添加し、前記試料中の測定対象物を不溶性担体に担持した反応特異的成分に捕捉し、未反応物を除去後、標識体を添加し、さらに未反応物を除去後、前記反応特異的成分に捕捉した測定対象物を定量する測定方法である。
Next, the third aspect of the present invention is as follows.
A sample is added to the above-described measurement reagent, the measurement target in the sample is captured by a reaction-specific component supported on an insoluble carrier, unreacted substances are removed, a label is added, and unreacted substances are further removed. Then, it is a measuring method for quantifying the measurement object captured by the reaction-specific component.
次に、本発明の第四の態様は、
上述した測定試薬に試料を添加し、前記試料中の測定対象物を不溶性担体に担持した反応特異的成分に捕捉し、標識体を添加し、未反応物を除去後、前記反応特異的成分に捕捉した測定対象物を定量する測定方法である。
Next, the fourth aspect of the present invention is as follows.
A sample is added to the above-described measurement reagent, the measurement object in the sample is captured by a reaction-specific component supported on an insoluble carrier, a label is added, unreacted substances are removed, and then the reaction-specific component is added. This is a measurement method for quantifying a captured measurement object.
次に、本発明の第五の態様は、
ウシ血清アルブミンを50〜60℃において10分〜24時間加熱処理する工程と、
前記加熱処理したウシ血清アルブミンの分子量画分を、分子量範囲300,000〜1,000,000に入るように分取する工程と、
前記ウシ血清アルブミンの分子量画分を0.1〜5.0%(w/v)濃度に調整し、測定対象物を特異的反応により捕捉する一以上の反応特異的成分を担持した不溶性担体を浸漬する工程と、
浸漬後の前記不溶性担体を希釈液にて希釈する工程と、
を含む測定試薬の製造方法である。
Next, the fifth aspect of the present invention provides
Heat treating bovine serum albumin at 50-60 ° C. for 10 minutes-24 hours;
Fractionating the molecular weight fraction of the heat-treated bovine serum albumin so as to fall within a molecular weight range of 300,000 to 1,000,000;
Adjusting the molecular weight fraction of bovine serum albumin to a concentration of 0.1 to 5.0% (w / v), and providing an insoluble carrier carrying one or more reaction-specific components for capturing the measurement object by a specific reaction. Dipping step;
Diluting the insoluble carrier after immersion with a diluent;
A method for producing a measurement reagent containing
本発明により、測定対象物を特異的反応により捕捉する一以上の反応特異的成分とウシ血清アルブミンの会合成分(分子量範囲300,000〜1,000,000に入る分子量画分)を担持した不溶性担体をヘテロジニアスアッセイ法の測定試薬に用いることにより標識体の担体への非特異吸着量を低減して偽高値を回避し、測定の再現性を改善することができる。 According to the present invention, insolubility carrying one or more reaction-specific components for capturing a measurement object by a specific reaction and an association component of bovine serum albumin (molecular weight fraction falling in the molecular weight range of 300,000 to 1,000,000). By using the carrier as a measurement reagent for the heterogeneous assay method, it is possible to reduce the amount of non-specific adsorption of the label to the carrier, avoid a false high value, and improve the reproducibility of the measurement.
以下に本発明を更に詳細に説明する。 The present invention is described in further detail below.
本発明における反応特異的成分とは、抗体や抗原の他、レセプター、酵素、アビジン、ビオチン、ストレプトアビジン、核酸等が例示できる。 Examples of the reaction-specific component in the present invention include antibodies, antigens, receptors, enzymes, avidin, biotin, streptavidin, nucleic acids and the like.
本発明におけるウシ血清アルブミンの会合成分とは、前記ウシ血清アルブミンを加熱、加圧、紫外線照射、超音波照射などの物理学的処理により、または酸、アルカリ、界面活性剤、有機溶媒、金属イオンなどを添加する化学的処理により変性させてウシ血清アルブミンが会合した成分、更には物理学的処理または化学的処理を行わずに未変性ウシ血清アルブミン(単量体を含む)を架橋剤により架橋し高分子量化した成分を指す。一般的に加熱により変性させた方が会合体を簡便に入手できる点において好ましく、通常、0.1〜10%(w/v)に濃度調整したウシ血清アルブミンを50〜60℃、好ましくは50〜56℃にて10分〜24時間、好ましくは1時間〜12時間の範囲で加熱すると、目的とする分子量の会合成分の混合物が得られる。ウシ血清アルブミンのグレードにより差はあるが、会合体成分の混合物は通常、単量体(加熱しても会合しない成分)、または二量体〜三量体の会合度の低い成分を含み、分子量範囲が広いため、分子量範囲300,000〜1,000,000、好ましくは分子量範囲400,000〜600,000、より好ましくは分子量範囲400,000〜520,000の会合成分を得るためには、ゲル浸透クロマトグラフィー等による分画を行うことが望ましい。担体に担持する会合成分の分子量画分は狭くても広くても前記分子量範囲内であればよく、特に単量体を含めて会合度の低い成分(二量体〜三量体)を除去するように分画すれば好適に使用することができる。 The association component of bovine serum albumin in the present invention refers to the bovine serum albumin by physical treatment such as heating, pressurization, ultraviolet irradiation, ultrasonic irradiation, or acid, alkali, surfactant, organic solvent, metal ion. Components that have been modified by chemical treatment to add bovine serum albumin and further, unmodified bovine serum albumin (including monomer) is cross-linked with a cross-linking agent without physical or chemical treatment. Refers to a component having a high molecular weight. In general, denaturation by heating is preferable in that the aggregate can be easily obtained. Usually, bovine serum albumin whose concentration is adjusted to 0.1 to 10% (w / v) is 50 to 60 ° C., preferably 50 When heated at ˜56 ° C. for 10 minutes to 24 hours, preferably 1 hour to 12 hours, a mixture of associative components of the intended molecular weight is obtained. Although there is a difference depending on the grade of bovine serum albumin, a mixture of aggregate components usually contains a monomer (a component that does not associate even when heated), or a dimer-trimer low-association component, and has a molecular weight In order to obtain an associative component having a molecular weight range of 300,000 to 1,000,000, preferably a molecular weight range of 400,000 to 600,000, more preferably a molecular weight range of 400,000 to 520,000 due to the wide range. It is desirable to perform fractionation by gel permeation chromatography or the like. The molecular weight fraction of the associating component supported on the carrier may be narrow or wide as long as it is within the above molecular weight range. In particular, components having low association degree (dimer to trimer) including monomers are removed. Thus, it can be suitably used if fractionated.
本発明における不溶性担体の形状は、粒子状、チューブ状、カップ状、プレート状などが例示できるが、粒子状、特に球状粒子の担体が好ましい。不溶性担体の材質は、ガラス、シリカなどの無機物質、各種合成高分子化合物からなるプラスチック、セルロ−ス誘導体など、ヘテロジニアス測定に用いられる担体であれば特に制限はない。一例として、ポリエチレン、ポリプロピレン、エチレン−酢酸ビニル共重合体、ナイロン、アクリル樹脂、メタクリル樹脂、ポリスチレン、スチレン−アクリル共重合体、スチレン−ブタジエン共重合体、ポリ塩化ビニル、またはこれらを主成分とする共重合体もしくは混合物といった熱可塑性樹脂製の担体、更にはこれらにカルボキシル基、スルホプロピル基、ジエチルアミノエチル基等のイオン交換基、トシル基、トレシル基、エポキシ基などの反応性官能基を導入したものがあげられる。担体の平均粒径についても特に制限はなく、例えば0.01〜10,000μmの粒径の担体を使用することができる。 Examples of the shape of the insoluble carrier in the present invention include a particulate shape, a tube shape, a cup shape, and a plate shape, but a particulate shape, particularly a spherical particle carrier is preferable. The material of the insoluble carrier is not particularly limited as long as it is a carrier used for heterogeneous measurement, such as an inorganic substance such as glass or silica, a plastic made of various synthetic polymer compounds, or a cellulose derivative. As an example, polyethylene, polypropylene, ethylene-vinyl acetate copolymer, nylon, acrylic resin, methacrylic resin, polystyrene, styrene-acrylic copolymer, styrene-butadiene copolymer, polyvinyl chloride, or these are the main components. A carrier made of a thermoplastic resin such as a copolymer or a mixture, and further, an ion exchange group such as a carboxyl group, a sulfopropyl group and a diethylaminoethyl group, and a reactive functional group such as a tosyl group, a tresyl group and an epoxy group were introduced into these carriers. Things can be raised. There is no restriction | limiting in particular also about the average particle diameter of a support | carrier, For example, the support | carrier of a particle diameter of 0.01-10,000 micrometers can be used.
本発明における不溶性担体は、磁気感応成分を含有しない担体でもよいが、磁気感応成分を含有した担体(磁性粒子)の方がその後の未反応成分の除去が容易となる点で好ましい。磁気感応性成分としては、例えばマンガン−亜鉛フェライトなどのソフトフェライト、四三酸化鉄を主成分とするマグネタイトなどがあげられる。磁気感応性成分は、前述した熱可塑性樹脂からなる担体の作製時に混合することで内部に一様に含有させてもよいし、多層構造からなる担体の1つの層に含有させてもよいし、吸着や熱融着などにより表面に担持させることで含有させてもよい。磁気感応性成分の担体への含有量(担持量)は、担体を流動させるために作用させる磁界の強度、担体の流動性の程度により適宜決定することができるが、通常は磁性粒子重量の1〜80%(w/v)であり、5〜50%(w/v)が好ましい。なお、磁気感応性成分そのものを、担体そのもの、または担体の核として用いてもよい。 The insoluble carrier in the present invention may be a carrier that does not contain a magnetically sensitive component, but a carrier (magnetic particle) that contains a magnetically sensitive component is preferred in terms of facilitating subsequent removal of unreacted components. Examples of the magnetically sensitive component include soft ferrites such as manganese-zinc ferrite and magnetite containing iron trioxide as a main component. The magnetically sensitive component may be uniformly contained inside by mixing at the time of producing the carrier made of the above-mentioned thermoplastic resin, or may be contained in one layer of the carrier having a multilayer structure, You may make it contain by making it carry | support by the surface by adsorption | suction or heat fusion. The content (supported amount) of the magnetically sensitive component on the carrier can be determined as appropriate depending on the strength of the magnetic field applied to flow the carrier and the degree of fluidity of the carrier. It is -80% (w / v), and 5-50% (w / v) is preferable. The magnetically sensitive component itself may be used as the carrier itself or the core of the carrier.
ウシ血清アルブミンの会合成分の担体への担持法は、測定対象物を特異的反応により捕捉する反応特異的成分を化学結合法または物理吸着法などの担持法により担体に担持したのち、前記ウシ血清アルブミンの会合成分を、担体表面に残存する非特異吸着部位に対し物理吸着法により担持する方法、または前記反応特異的成分を担体表面の官能基を用いて化学結合法により担持したのち、前記ウシ血清アルブミンの会合成分を担体表面に残存する官能基を利用して化学結合法にて直接、もしくは架橋剤を介して担持する方法などが例示されるが、担体の材質または担体表面の官能基等に合わせて適宜最適な方法で担持すればよい。不溶性担体に担持するための前記会合成分の添加濃度は、0.1〜5%(w/v)が好ましく、より好ましくは0.5〜3%(w/v)である。 The method for supporting bovine serum albumin on the carrier is a method in which the reaction-specific component for capturing the measurement object by a specific reaction is supported on the carrier by a supporting method such as a chemical binding method or a physical adsorption method, and then the bovine serum A method in which the association component of albumin is supported by a physical adsorption method on a non-specific adsorption site remaining on the surface of the carrier, or after the reaction-specific component is supported by a chemical bonding method using a functional group on the surface of the carrier, the bovine Examples include a method of supporting an association component of serum albumin directly by a chemical bonding method using a functional group remaining on the surface of the carrier or via a cross-linking agent. It may be supported by an optimum method as appropriate. The concentration of the association component added to the insoluble carrier is preferably 0.1 to 5% (w / v), more preferably 0.5 to 3% (w / v).
本発明の測定試薬の形態は、測定対象物を特異的反応により捕捉する一以上の反応特異的成分およびウシ血清アルブミンの会合成分を担持した不溶性担体を希釈液にて懸濁した状態でそのまま使用してもよく、前記懸濁液を凍結乾燥して使用してもよい。 The form of the measurement reagent of the present invention is used as it is in a state in which one or more reaction-specific components for capturing a measurement object by a specific reaction and an insoluble carrier carrying an association component of bovine serum albumin are suspended in a diluent. Alternatively, the suspension may be lyophilized for use.
また、上述した希釈液は、哺乳動物の正常血清タンパク質、アルブミン、コラーゲン、ゲリゼート、スキムミルク、乳酸発酵物、ゼラチンもしくはその分解物などのタンパク質、またはD−マンニトール、シュークロース、myo―イノシトール、トレハロース、β―シクロデキストリン、グルコース、ラクトース、フルクトース、セルロース、ラフィノース、マルトース、ガラクトース、キシロースなどの糖を含有する。その濃度は特に限定されないが、タンパク質に関しては、好ましくは0.1〜50%(w/v)、より好ましくは1〜15%(w/v)、糖に関しては、好ましくは1〜10%(w/v)、より好ましくは1〜5%(w/v)である。タンパク質または糖以外に、目的に応じてBSAまたはカゼイン等の保護剤、アスコルビン酸、ビタミンE等の抗酸化剤、カルボキシメチルセルロース等の結合剤、セルロース、ポロエチレングリコール等の湿潤剤、ポリビニルピロリドン等の懸濁化剤、アルキルスルホン酸等の乳化剤、グリセリン等の溶解補助剤、リン酸塩、トリスヒドキシルアミン塩酸塩等の緩衝剤、D−ソルビトール、塩化ナトリウム等の等張化剤、塩化マグネシウム、塩化亜鉛、TritonX−100、Tween20等の界面活性剤などが添加されていても良い。 In addition, the above-mentioned diluent is a protein such as mammalian normal serum protein, albumin, collagen, gelisate, skim milk, lactic acid fermented product, gelatin or a degradation product thereof, or D-mannitol, sucrose, myo-inositol, trehalose, Contains sugars such as β-cyclodextrin, glucose, lactose, fructose, cellulose, raffinose, maltose, galactose, and xylose. The concentration is not particularly limited, but is preferably 0.1 to 50% (w / v), more preferably 1 to 15% (w / v) for proteins, and preferably 1 to 10% (for sugars). w / v), more preferably 1 to 5% (w / v). In addition to protein or sugar, depending on the purpose, protective agents such as BSA or casein, antioxidants such as ascorbic acid and vitamin E, binders such as carboxymethyl cellulose, wetting agents such as cellulose and polyethylene glycol, polyvinylpyrrolidone, etc. Suspending agents, emulsifiers such as alkyl sulfonic acids, solubilizing agents such as glycerin, buffers such as phosphates and tris-hydroxylamine hydrochloride, isotonic agents such as D-sorbitol and sodium chloride, magnesium chloride, A surfactant such as zinc chloride, Triton X-100, or Tween 20 may be added.
本発明の測定試薬を用いた測定方法とは、例えば、測定容器に前記測定試薬および試料を添加して攪拌し、前記試料中の測定対象物を不溶性担体に担持した第一の反応特異的成分に捕捉し、捕捉されなかった前記試料中の夾雑成分を除去(1回目のB/F分離)後、不溶性担体を洗浄液にて洗浄し、さらに測定対象物と特異的に反応する第二の反応特異的成分に標識物を結合した標識体を添加して撹拌し、不溶性担体に捕捉した前記測定対象物に対して前記標識体を反応させてサンドイッチ複合体(第一の反応特異的成分−測定対象物−標識体)を形成し、未反応物を除去(2回目のB/F分離)後、前記サンドイッチ複合体に含まれる前記標識体の標識物から生じるシグナルに基づいて前記測定対象物を定量する測定法があげられる。 The measurement method using the measurement reagent of the present invention is, for example, the first reaction-specific component in which the measurement reagent and sample are added to a measurement container and stirred, and the measurement object in the sample is supported on an insoluble carrier. The second reaction in which the insoluble carrier is washed with a washing solution and specifically reacts with the measurement target after removing contaminant components in the sample that have been trapped in the sample and not captured (first B / F separation). A labeled body in which a labeled substance is bound to a specific component is added and stirred, and the labeled body is reacted with the measurement target captured on an insoluble carrier to form a sandwich complex (first reaction-specific component-measurement). (Object-labeled body) and unreacted substances are removed (second B / F separation), and then the measurement object is converted based on the signal generated from the labeled object of the label contained in the sandwich complex. Measurement methods for quantification are included.
また、測定容器に前記測定試薬および試料を添加して攪拌し、前記試料中の測定対象物を不溶性担体に担持した反応特異的成分に捕捉し、さらに測定対象物に標識物を結合した標識体を添加して撹拌し、未反応物を除去(B/F分離)後、不溶性担体に担持した反応特異的成分に捕捉した前記標識体の標識物から生じるシグナルに基づいて前記測定対象物を定量する測定法もあげられる。 In addition, the measurement reagent and the sample are added to the measurement container and stirred, the measurement object in the sample is captured by the reaction-specific component supported on the insoluble carrier, and the label is further bound to the measurement object. Is added and stirred to remove unreacted substances (B / F separation), and then the measurement object is quantified based on the signal generated from the label of the labeled body captured by the reaction-specific component supported on the insoluble carrier. There are also measuring methods to do.
本発明で用いる標識体とは、測定対象物と特異的に反応する反応特異的成分に標識物を標識したもの、あるいは前記測定対象物に標識物を標識したものがあげられ、前記標識物には、アルカリ性ホスファターゼ、ペルオキシダーゼ、β−D−ガラクトシダーゼ、グルコースオキシダーゼ、ルシフェラーゼなどの酵素、アクリジニウム誘導体やルミノール誘導体などの発光物質、フルオレセイン誘導体やローダミン誘導体などの蛍光物質などが例示でき、通常の酵素免疫測定法や発光または蛍光免疫測定法などに用いられるものであれば特に制限はない。標識体試薬の形態は、前記担体試薬と同様に溶液で使用してもよく、凍結乾燥して使用してもよい。さらには、前記標識体試薬は前記担体試薬と混合し、同じ容器内で凍結乾燥して使用してもよく、前記標識体試薬と前記担体試薬をそれぞれ別の容器に凍結乾燥して使用してもよい。 Examples of the label used in the present invention include those obtained by labeling a reaction-specific component that specifically reacts with an object to be measured with a label, or those obtained by labeling the object to be measured. Examples include alkaline phosphatase, peroxidase, β-D-galactosidase, glucose oxidase, luciferase and other luminescent materials such as acridinium derivatives and luminol derivatives, and fluorescent materials such as fluorescein derivatives and rhodamine derivatives. There is no particular limitation as long as it is used for a method or a luminescence or fluorescence immunoassay. The form of the labeled reagent may be used in the same manner as the carrier reagent, or may be used after lyophilization. Further, the label reagent may be mixed with the carrier reagent and lyophilized in the same container, or the label reagent and the carrier reagent may be lyophilized in separate containers. Also good.
本発明の測定試薬の製造方法とは、例えば、Tris塩酸緩衝液またはリン酸緩衝液などの緩衝液で0.1〜10%(w/v)に濃度調整したウシ血清アルブミン溶液をポリプロピレン製等の容器に入れ、温浴にて50〜60℃において10分〜24時間加熱処理する工程と、加熱処理したウシ血清アルブミン溶液を室温に戻した後、ゲル浸透クロマトグラフィー用カラムをセットした高速液体クロマトグラフを用いてウシ血清アルブミンの会合成分の分子量画分を分子量範囲300,000〜1,000,000に入るように分取する工程と、反応特異的成分を不溶性担体に担持する際に用いた緩衝液と同じ組成の緩衝液にて前記会合成分の溶液を0.1〜5.0%(w/v)濃度に調整し、測定対象物を特異的反応により捕捉する一以上の反応特異的成分を担持した不溶性担体を25〜37℃において1〜12時間程度、前記会合成分の溶液に浸漬して不溶性担体をブロッキングする工程と、ブロッキングが終了した前記不溶性担体を0.1〜50%(w/v)のタンパク質または1〜10%(w/v)の糖を含む緩衝液にて希釈する工程と、を含む製造方法があげられる The method for producing a measuring reagent of the present invention is, for example, a polypropylene bovine serum albumin solution whose concentration is adjusted to 0.1 to 10% (w / v) with a buffer such as Tris-HCl buffer or phosphate buffer. A high temperature liquid chromatograph in which a column for gel permeation chromatography is set after the step of heat treatment in a warm bath at 50 to 60 ° C. for 10 minutes to 24 hours, and the heated bovine serum albumin solution is returned to room temperature. The step of separating the molecular weight fraction of the associative component of bovine serum albumin using a graph so as to fall within the molecular weight range of 300,000 to 1,000,000, and the reaction-specific component was used when supported on an insoluble carrier. One or more in which the solution of the association component is adjusted to a concentration of 0.1 to 5.0% (w / v) with a buffer solution having the same composition as the buffer solution, and the measurement target is captured by a specific reaction. A step of blocking the insoluble carrier by immersing the insoluble carrier carrying the reaction-specific component in a solution of the association component at 25 to 37 ° C. for about 1 to 12 hours; And a step of diluting with a buffer containing 50% (w / v) protein or 1-10% (w / v) sugar.
以下、実施例を用いて本発明をさらに詳細に説明するが、これら実施例は本発明を限定するものではない。 EXAMPLES Hereinafter, although this invention is demonstrated further in detail using an Example, these Examples do not limit this invention.
(実施例1)
1.0%のBSA(フラクションV、シグマ製)を含む0.05mol/L Tris塩酸緩衝液(pH8.0)を50℃、7時間温浴で加熱し、BSAの会合成分を含む溶液を得た。これを0.22μmフィルターで処理した後、TSK gel G3000SWXLゲル浸透クロマトグラフィー用カラムを用いて分離したのち紫外吸光検出器(検出波長280nm)にて検出し、平均分子量約480,000(分子量400,000〜520,000の画分)のBSAの会合成分を含む画分(図1の破線枠の部分を分取)を得た。タンパク質濃度は、BCA Protein Assay Kit(Pierce製)を用いて測定した。
Example 1
A 0.05 mol / L Tris hydrochloric acid buffer solution (pH 8.0) containing 1.0% BSA (fraction V, manufactured by Sigma) was heated in a warm bath at 50 ° C. for 7 hours to obtain a solution containing an association component of BSA. . This was treated with a 0.22 μm filter, separated using a TSK gel G3000SW XL gel permeation chromatography column, and then detected with an ultraviolet absorption detector (detection wavelength 280 nm). The average molecular weight was about 480,000 (molecular weight 400). , 5,000 to 520,000 fractions) containing a BSA association component (fractionated by the broken line in FIG. 1). The protein concentration was measured using BCA Protein Assay Kit (Pierce).
次に、不溶性担体として磁性微粒子(材質:磁性体含有ビニルポリマーコーティング微粒子、平均粒径2.1μm、磁性体の種類:マグネタイト、磁性体の量:30〜50%)を0.01mol/L MES緩衝液(pH6.0)中で1%(w/v)スラリー濃度に調整し、抗甲状腺刺激ホルモン抗体(以下、抗TSH抗体とする)を0.2mg/mLの濃度となるように加え、37℃で1時間インキュベートして抗TSH抗体を磁性微粒子に物理吸着した。磁性微粒子を洗浄後、上述したBSAの1.0%会合成分溶液中にて37℃、7時間インキュベートしてBSAの会合成分を磁性微粒子にブロッキング(物理吸着)し、抗TSH抗体固定化磁性微粒子とし、更に5%ウシ血清を含む0.05mol/L Tris塩酸緩衝液(pH8.0)で希釈し、希釈固相懸濁液を作製し、凍結乾燥して測定試薬とした。 Next, 0.01 mol / L MES of magnetic fine particles (material: magnetic material-containing vinyl polymer coated fine particles, average particle size 2.1 μm, type of magnetic material: magnetite, amount of magnetic material: 30 to 50%) as an insoluble carrier. Adjust the slurry concentration to 1% (w / v) in buffer (pH 6.0), add antithyroid stimulating hormone antibody (hereinafter referred to as anti-TSH antibody) to a concentration of 0.2 mg / mL, The anti-TSH antibody was physically adsorbed on the magnetic microparticles by incubating at 37 ° C. for 1 hour. After washing the magnetic fine particles, the BSA-associated components are blocked (physically adsorbed) by incubating in the aforementioned BSA 1.0% associating component solution at 37 ° C. for 7 hours, and anti-TSH antibody-immobilized magnetic fine particles are obtained. And diluted with 0.05 mol / L Tris hydrochloric acid buffer (pH 8.0) containing 5% bovine serum to prepare a diluted solid phase suspension and lyophilized to obtain a measurement reagent.
(比較例1)
磁性微粒子のブロッキングを非会合のBSA(非加熱、単量体の他、一部二量体および三量体を含む)(分子量66,000(主画分)〜200,000の画分)の1.0%溶液中で行った以外は実施例1と同様の方法で希釈固相懸濁液を作製し、凍結乾燥して測定試薬とした。
(Comparative Example 1)
Non-associated BSA for blocking magnetic particles (non-heated, monomer, as well as some dimers and trimers) (fraction of molecular weight 66,000 (main fraction) to 200,000) A diluted solid phase suspension was prepared in the same manner as in Example 1 except that it was performed in a 1.0% solution, and lyophilized to obtain a measurement reagent.
(化学発光酵素免疫測定法による評価)
抗TSH抗体とアルカリ性ホスファターゼの結合物を、5%ウシ血清を含む0.05mol/L Tris塩酸緩衝液(pH8.0)で希釈したものを凍結乾燥し、検出用標識抗体試薬(以下、標識抗体試薬とする)とし、5%ウシ血清となるように0.03mol/L トリス塩酸緩衝液(pH8.0)で希釈したものをTSH測定用のゼロ濃度標準溶液(以下、TSH標準溶液とする)とした。
(Evaluation by chemiluminescent enzyme immunoassay)
A conjugate of anti-TSH antibody and alkaline phosphatase diluted with 0.05 mol / L Tris hydrochloric acid buffer (pH 8.0) containing 5% bovine serum is lyophilized and labeled antibody reagent for detection (hereinafter labeled antibody) A zero-concentration standard solution for TSH measurement (hereinafter referred to as TSH standard solution) diluted with 0.03 mol / L Tris-HCl buffer (pH 8.0) to 5% bovine serum. It was.
図2は実施例1で作製したと比較例1で作製した凍結乾燥品を用いてTSH標準溶液を化学発光酵素免疫測定法により60回測定した結果を示す図である。 FIG. 2 is a diagram showing the results of measuring a TSH standard solution 60 times by a chemiluminescent enzyme immunoassay using the lyophilized product prepared in Example 1 and the lyophilized product prepared in Comparative Example 1.
測定は以下の手順により行った。
測定試薬を、界面活性剤を含む純水およびゼロ濃度のTSH標準溶液で溶解した後、37℃にて5分間免疫反応を行い、1回目のB/F分離を行った。次に界面活性剤を含む純水で溶解した標識抗体試薬を加えて37℃にて3分間免疫反応を行い、2回目のB/F分離を行った。その後、アルカリ性ホスファターゼに対する化学発光基質(DIFURAT、3−(5−tert−ブチル−4,4−ジメチル−2,6,7−トリオキサビシクロ[3,2,0]ヘプト−1−イル)フェニルリン酸エステル ジナトリウム塩)および化学発光補助試薬を加え、発光強度(count(s)/second(cps))を測定した。結果を表1に示す。
The measurement was performed according to the following procedure.
The measurement reagent was dissolved in pure water containing a surfactant and a zero-concentration TSH standard solution, and then subjected to an immunoreaction at 37 ° C. for 5 minutes to perform the first B / F separation. Next, a labeled antibody reagent dissolved in pure water containing a surfactant was added, and an immunoreaction was performed at 37 ° C. for 3 minutes, and a second B / F separation was performed. Thereafter, a chemiluminescent substrate for alkaline phosphatase (DIFURAT, 3- (5-tert-butyl-4,4-dimethyl-2,6,7-trioxabicyclo [3,2,0] hept-1-yl) phenyl phosphorus Acid ester disodium salt) and a chemiluminescence auxiliary reagent were added, and the luminescence intensity (count (s) / second (cps)) was measured. The results are shown in Table 1.
Claims (9)
前記測定試薬に試料を添加し、前記試料中の測定対象物を反応特異的成分に捕捉し、未反応物を除去後、標識体を添加し、さらに未反応物を除去後、前記反応特異的成分に捕捉した前記測定対象物を定量する前記測定方法。 A measurement method using the measurement reagent according to claim 5 or 6,
A sample is added to the measurement reagent, a measurement target in the sample is captured by a reaction-specific component, an unreacted substance is removed, a label is added, and an unreacted substance is further removed. The said measuring method which quantifies the said measuring object capture | acquired by the component.
前記測定試薬に試料を添加し、前記試料中の測定対象物を反応特異的成分に捕捉し、標識体を添加し、未反応物を除去後、前記反応特異的成分に捕捉した測定対象物を定量する前記測定方法。 A measurement method using the measurement reagent according to claim 5 or 6,
A sample is added to the measurement reagent, the measurement object in the sample is captured by a reaction-specific component, a label is added, an unreacted material is removed, and the measurement object captured by the reaction-specific component is The measuring method for quantification.
前記加熱処理したウシ血清アルブミンの分子量画分を、分子量範囲300,000〜1,000,000に入るように分取する工程と、
前記ウシ血清アルブミンの分子量画分を0.1〜5.0%(w/v)濃度に調整し、測定対象物を特異的反応により捕捉する一以上の反応特異的成分を担持した不溶性担体を浸漬する工程と、
浸漬後の前記不溶性担体を希釈液にて希釈する工程と、
を含む測定試薬の製造方法。 Heat treating bovine serum albumin at 50-60 ° C. for 10 minutes-24 hours;
Fractionating the molecular weight fraction of the heat-treated bovine serum albumin so as to fall within a molecular weight range of 300,000 to 1,000,000;
Adjusting the molecular weight fraction of bovine serum albumin to a concentration of 0.1 to 5.0% (w / v), and providing an insoluble carrier carrying one or more reaction-specific components for capturing the measurement object by a specific reaction. Dipping step;
Diluting the insoluble carrier after immersion with a diluent;
A method for producing a measurement reagent comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017030005A JP2018136179A (en) | 2017-02-21 | 2017-02-21 | Measurement reagent with absorbed protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017030005A JP2018136179A (en) | 2017-02-21 | 2017-02-21 | Measurement reagent with absorbed protein |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2018136179A true JP2018136179A (en) | 2018-08-30 |
Family
ID=63365394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017030005A Pending JP2018136179A (en) | 2017-02-21 | 2017-02-21 | Measurement reagent with absorbed protein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2018136179A (en) |
-
2017
- 2017-02-21 JP JP2017030005A patent/JP2018136179A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10161935B2 (en) | Test substance measurement kit and test substance measurement method | |
JP2009098138A (en) | Method of high sensitive immunoassay | |
JP2015072249A (en) | Test substance assay method, test substance assay kit, and test substance assay reagent | |
WO2017138497A1 (en) | Analyte detection method and reagent kit for detecting analyte | |
CN104777315A (en) | Chemiluminescence immunoassay method for detecting S100 based on gold magnetic particles | |
US11768209B2 (en) | Method and reagent for measuring thyroglobulin | |
JP2011137694A (en) | Freeze-dried reagent | |
JP4086266B2 (en) | Immunoassay method | |
JP2022152733A (en) | Method of enhancing storage stability of antibody-bound magnetic particles | |
JP2018136179A (en) | Measurement reagent with absorbed protein | |
JP3841559B2 (en) | Immunological examination method and immunological examination kit | |
JP5465758B2 (en) | Thyroxine immunoassay using fluorescent particles | |
JP2596959B2 (en) | Ligand assays | |
CN112062837A (en) | Rapid detection test paper for HPV16 type virus antibody | |
JP5137880B2 (en) | Method for producing dry particles with immobilized binding substance | |
JP2002122599A (en) | Immunoassay | |
JPH08220095A (en) | Heterogeneous immunoassay using solid phase that can undergosedimentation | |
JP6705245B2 (en) | Method for producing an immunoreaction reagent for measuring anti-thyroglobulin antibody | |
JP2000019175A (en) | Immunological examination method, and kit for immunological examination | |
JP2000028612A (en) | Immunological inspection method and immunological inspection kit thereof | |
JPH07159406A (en) | Washing liquid and method | |
JPH07306204A (en) | Immunoassay | |
JPH06148188A (en) | Immunological reinspecting method | |
CN117664672A (en) | Solution for improving matrix effect and application thereof | |
JP2000028610A (en) | Immunological inspection method and immunological inspection kit thereof |